A detailed history of Pensionmark Financial Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Pensionmark Financial Group, LLC holds 12,298 shares of MRNA stock, worth $304,498. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,298
Holding current value
$304,498
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$23.51 - $34.67 $289,125 - $426,371
12,298 New
12,298 $317,000
Q1 2025

Apr 29, 2025

BUY
$28.35 - $47.53 $61,321 - $102,807
2,163 Added 30.47%
9,262 $262,000
Q4 2024

Feb 12, 2025

BUY
$36.85 - $63.93 $261,598 - $453,839
7,099 New
7,099 $295,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pensionmark Financial Group, LLC Portfolio

Follow Pensionmark Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionmark Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pensionmark Financial Group, LLC with notifications on news.